TIM-3 expression is found in all infiltrating cells present in breast cancer and correlates with other immune checkpoint inhibitors such as LAG-3, CTLA-4, and PD-1, which may underscore the importance of their interaction in the microenvironment [131, 134]. This evidence concerns the gene HAVCR2 and breast cancer.